Sagent Pharmaceuticals Enters Ophthalmic Market, Launches Travoprost Ophthalmic Solution
Travoprost is the first ophthalmic product offering in Sagent's portfolio, with plans to launch more products in the coming year.
Ophthalmic Market | 16/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy